Vedanta Biosciences is a biopharmaceutical company focused on developing innovative medicines for gastrointestinal diseases, with its lead candidate, VE303, currently in a Phase 3 trial for recurrent C. difficile infection. What sets us apart is our advanced product engine that leverages one of the largest libraries of human microbiome bacteria and proprietary consortium design capabilities to deliver targeted oral therapies.
No jobs found. Subscribe below to get notified when we find something for you.
Searching